Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial
Anna‐Katharina Zoellner(Ludwig-Maximilians-Universität München), Eva Hoster(Zimmer Biomet (Germany)), Stephan Stilgenbauer(Universität Ulm), Christian Schmidt(Ludwig-Maximilians-Universität München), Catherine Thiéblemont(Assistance Publique – Hôpitaux de Paris), Lorenz Truemper(University of Göttingen), Georg Lenz(University Hospital Münster), Hanneke C. Kluin‐Nelemans(University Medical Center Groningen), Martin Dreyling(LMU Klinikum), Marc André(CHU Dinant Godinne UCL Namur), Kai Hübel(University Hospital Cologne), Achiel Van Hoof(AZ Sint-Jan), Vibeke Vergote(KU Leuven), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Max S. Topp(European Neuroendocrine Tumor Society), Kamal Bouabdallah(Université de Bordeaux), Jürgen Krauter(Goethe University Frankfurt), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Jan Dürig(West German Heart and Vascular Center Essen), Michael Unterhalt, Bernd Metzner(Klinikum Oldenburg)
Cited by 53
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k